The Investigative Journal’s daily review of the Federal Register — the federal government’s official record of rules, proposed rules, notices, and presidential documents. All items below are drawn from documents filed for publication in the August 27, 2026 edition.
Today’s Federal Register carries 103 documents: 23 final rules, 8 proposed rules, and 72 notices, according to the Office of the Federal Register’s public inspection list. The headline action is at the Treasury Department, which is formally publishing the legal instruments behind last week’s sweeping expansion of Iran sanctions authority. The Drug Enforcement Administration schedules two separate drug actions, the FAA orders inspections of Boeing 787 wings, and the EPA opens a 60-day comment window on a widely used industrial solvent. Here is what matters and why.
1. Treasury codifies five-sector Iran sanctions expansion — and winds down longstanding general licenses
The Office of Foreign Assets Control is publishing a sector determination under Executive Order 13902 extending blocking sanctions authority to the aviation, digital asset, gold, shipping, and technology sectors of the Iranian economy. The determination, issued August 24 and effective the same day, means any person found by Treasury to operate in those sectors can have U.S.-reachable property blocked — the same sector-based authority OFAC has long wielded over Iran’s financial and petroleum industries. Treasury announced the move as part of what it calls “Operation Economic Outcast,” a campaign that, according to the department’s release and independent analysis by TRM Labs, included designations of nearly 60 Iran-linked targets.
A companion document publishes Iran-related General Licenses AA and BB. GL AA authorizes wind-down and maintenance transactions involving La Nivernaise De Raffinage SAS, and entities it majority-owns, through October 23, 2026. GL BB is the quieter but broader change: it gives U.S. persons only until 12:01 a.m. EDT on September 8, 2026 to wind down transactions previously permitted under three longstanding general licenses in the Iranian Transactions and Sanctions Regulations — covering certain educational activities in third countries (31 CFR 560.544), noncommercial personal remittances to and from Iran (560.550), and conference-related services (560.554). Records indicate the remittance authorization has been a principal lawful channel for Iranian-Americans supporting family members in Iran; its wind-down is a significant tightening that affected families and universities will need to act on within days.
2. DEA places cipepofol, a new Chinese-developed anesthetic, in Schedule IV
The DEA is issuing an interim final rule placing cipepofol in Schedule IV of the Controlled Substances Act, effective on publication today. The FDA approved the drug on May 29, 2026, under the brand name Cypsedo for induction of general anesthesia in adults undergoing surgery; the scheduling follows a Department of Health and Human Services recommendation, and the CSA’s expedited process for newly approved medicines required DEA to act within 90 days. Cipepofol, developed by China’s Haisco Pharmaceutical Group, is the first China-originated intravenous anesthetic approved for the U.S. market, according to the company. Hospitals and anesthesia practices adopting the drug will now face Schedule IV registration, recordkeeping, and security requirements. Comments on the interim rule are due within 30 days of today’s publication.
3. DEA invokes emergency authority against four novel synthetic opioids
In a separate temporary scheduling order, the DEA places four novel compounds of the “chlorphine” family — 5,6-dichloro brorphine (SR-14968), 5,6-dichloro desmethylchlorphine (SR-17018), N-propionitrile chlorphine, and spirochlorphine — in Schedule I, effective today through August 27, 2028. The agency states the action is necessary “to avoid an imminent hazard to public safety,” the statutory trigger for emergency scheduling. The order imposes full Schedule I criminal, civil, and administrative controls on anyone who manufactures, distributes, imports, or possesses the substances. The action reflects the government’s continuing race with clandestine chemists who modify benzimidazolone and piperidine scaffolds faster than the permanent scheduling process can respond.
4. FAA orders repetitive wing-splice inspections on Boeing 787s
The FAA is adopting a new airworthiness directive covering Boeing 787-8, -9, and -10 airplanes after a Boeing investigation into manufacturing errors found that shim gaps at lower side-of-body splice plates may have exceeded engineering allowances, and that high pull-up forces could cause fatigue cracks at fastener holes. The AD requires repetitive ultrasonic and detailed inspections of splice plates, spar terminal fittings, lower chords, and jack pads, with on-condition repairs. The FAA estimates the directive affects 17 U.S.-registered airplanes at up to $24,310 per airplane per inspection cycle — up to $413,270 fleetwide per cycle — though Boeing indicates some costs may be covered under warranty. The AD takes effect 35 days after publication. It is one of six airworthiness directives in today’s issue, alongside two for Airbus transport airplanes, one for Lycoming engines, and one for Bell Textron helicopters.
5. EPA opens 60-day comment period on trans-1,2-dichloroethylene risk evaluation
The EPA is announcing the draft risk evaluation for trans-1,2-dichloroethylene, a solvent used in degreasing, refrigerants, and chemical manufacturing, under the Toxic Substances Control Act. TSCA risk evaluations determine whether a chemical presents an “unreasonable risk” to health or the environment under its conditions of use — without regard to cost — and a final unreasonable-risk finding obligates EPA to write binding risk-management rules. That makes this draft the opening move in what could become use restrictions or workplace limits. Comments are due 60 days from today’s publication, in docket EPA-HQ-OPPT-2018-0465 at regulations.gov. Manufacturers, downstream users, and public-health groups all have a stake in the record built here.
6. NTIA schedules listening session on screens in K-12 classrooms, tied to FCC E-Rate review
The National Telecommunications and Information Administration will hold a virtual listening session on September 15, 2026, from 7:00 to 8:30 p.m. EDT on screen use in schools, feeding into the FCC’s open rulemaking that asks whether the multibillion-dollar E-Rate program “is serving the long-term interests of children — or instead encouraging excessive screen-based instruction in K-12 schools at the expense of child development and academic outcomes,” as the notice puts it. The session invites parents, students, educators, and child-development specialists. The underlying FCC proposed rulemaking published August 14 remains open for public comment, and any eventual changes could redirect how billions in universal-service subsidies flow to schools and libraries.
7. Justice Department publishes firearms-rights restorations for nine individuals
A DOJ notice records that the Attorney General granted relief from federal firearms disabilities to nine individuals under 18 U.S.C. 925(c) — eight approved May 18, 2026, and one on August 5, 2026, per the notice signed by Acting Deputy Attorney General Trent McCotter. Section 925(c) allows a person prohibited from possessing firearms to petition for restoration upon a finding that they are “not likely to act in a manner dangerous to public safety.” The filing states the determinations were made by then-Acting Attorney General Todd Blanche after review of each applicant’s record. These notices merit watching: the relief process had been dormant for roughly three decades under appropriations riders before the department revived it, and the Federal Register is the only place the grants are systematically disclosed.
On our beats
Three smaller items intersect with The Investigative Journal’s accountability files. First, the Civil Rights Cold Case Records Review Board rejected four Justice Department postponement requests and ordered 32 pages released in full and 33 in part from cold-case incident 2023-002-006 — a small but notable assertion of independent declassification authority over DOJ objections. Second, the CDC is disclosing sole-source cooperative agreements of roughly $2 million each for fiscal 2026 to the Vietnam Administration of Medical Services, Vietnam’s National Institute of Medical Research, and the ASEAN+3 FETN Foundation, with expected totals near $10 million apiece over the award periods — noncompetitive foreign health spending we will track against results. Third, the Defense Acquisition Regulations System is seeking OMB clearance for its information collection on organizational conflicts of interest in major defense acquisition programs — the DFARS mitigation-plan requirement that is the paper trail for policing contractor conflicts; comments run 30 days from publication. And for Kansas readers: the SBA issued an economic injury disaster loan declaration for April’s severe storms, with applications open through May 21, 2027.
The full August 27, 2026 issue is available at federalregister.gov. Comment deadlines stated as relative periods are computed from today’s publication date; consult each document’s DATES section for the controlling date. Entities named in agency documents are reported as identified in the public record; none of the items above states a finding of wrongdoing unless the source document says so.